Solomon David

Davis Entertainment Co. is a music management and career direction company that manages a roster of music acts across various genres, including The Agonist, Cannibal Corpse, Children of Bodom, Entheos, Havok, Ministry, Monster Magnet, Queensrÿche, Revocation, and Whitechapel. The company is based in Los Angeles, CA. The company's core services focus on music management and guiding artists' careers.

Operates as a contract development and manufacturing organization that develops clinical and commercial volume aseptic filling, lyophilization & oral solid dose medicines

The private company is based in New Haven, CT. The association offers a comprehensive range of activities including mainstage and experimental productions, student resources, and opportunities for involvement in its active theater season, notably the 2025-2026 lineup featuring shows like "Mean Girls." The organization maintains extensive historical archives of its productions and provides technical and rehearsal support roles, costume resources, and rehearsal spaces primarily for its members. It encourages community engagement through donations, accessible ticketing options, and outreach initiatives. The Yale University Dramatic Association, founded in 1901, is Yale's oldest and largest undergraduate theatrical organization, dedicated to fostering a supportive and inclusive environment for diverse theatremakers.

Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments.

Functions as a College/University

Hildred Capital invests in middle market companies located in the United States with an enterprise value of USD 50 - 500 million and revenues of USD 10 - 100 million. The firm targets companies operating in the fields of healthcare services, consumer products, information technology, medical devices and pharmaceuticals products sectors. It provides financing for growth and buyout stage capital transactions with an investment size of USD 25 - 300 million. The firm also acquires majority and minority stake positions.

Provides dermatology and aesthetic medicine services

Engages in the production and sale of cannabis-based medicinal products

Develops protein sequencing technologies to decode molecules life